Related Experiment Videos
Obstructive sleep apnea and cardiovascular disease.
Jo-Dee L Lattimore1, David S Celermajer, Ian Wilcox
1Department of Cardiology, Royal Prince Alfred Hospital, NSW, Sydney, Australia. jodee.lattimore@email.cs.nsw.gov.au
Journal of the American College of Cardiology
|May 14, 2003
Summary
Obstructive sleep apnea (OSA) is a serious condition linked to heart disease. Effective treatments like CPAP exist, but OSA is often underdiagnosed due to lack of physician awareness.
Area of Science:
- Cardiology
- Pulmonology
- Sleep Medicine
Background:
- Obstructive sleep apnea (OSA) is a prevalent disorder.
- OSA is independently associated with cardiovascular disease, stroke, hypertension, and other cardiac conditions.
- Obesity is a significant risk factor for OSA, and weight loss can mitigate its severity.
Purpose of the Study:
- To review the association between OSA and cardiovascular disease.
- To discuss the role of CPAP in managing OSA and its cardiovascular implications.
- To highlight the underdiagnosis and undertreatment of OSA.
Main Methods:
- Literature review of studies on OSA and cardiovascular outcomes.
- Analysis of data on the efficacy of CPAP treatment.
- Discussion of factors contributing to OSA underdiagnosis.
Main Results:
- OSA is an independent risk factor for hypertension, congestive heart failure, pulmonary hypertension, arrhythmias, and atherosclerosis.
- Nasal continuous positive airway pressure (CPAP) therapy effectively eliminates apnea and improves cardiovascular parameters.
- Long-term CPAP use reduces nocturnal cardiac ischemia and improves blood pressure and left ventricular function.
Conclusions:
- OSA is a significant, independent risk factor for cardiovascular disease.
- CPAP is an effective treatment for OSA, improving cardiovascular health.
- Underdiagnosis and undertreatment of OSA persist, largely due to insufficient physician awareness.